rabeprazole has been researched along with rabeprazole-thioether in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Habuchi, T; Miura, M; Satoh, S; Suzuki, T; Tada, H | 1 |
Niioka, T; Shimizu, M; Sugawara, K; Tateishi, T; Uno, T; Yasui-Furukori, N | 1 |
Kim, A; Lee, BJ; Park, MJ; Ren, S | 1 |
Solanki, B; Thyssen, A; Treem, W | 1 |
Agbokponto, JE; Ding, L; Liu, R; Simpemba, E; Sun, C | 1 |
Ding, L; Jia, Y; Li, X; Lu, C; Shi, L; Song, Y; Sun, Y; Wang, S; Wen, A; Zhao, J | 1 |
2 trial(s) available for rabeprazole and rabeprazole-thioether
Article | Year |
---|---|
Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Algorithms; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Clarithromycin; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Double-Blind Method; Enzyme Inhibitors; Female; Fluvoxamine; Half-Life; Heterozygote; Homozygote; Humans; Male; Mixed Function Oxygenases; Rabeprazole; Regression Analysis; Sulfides; Time Factors | 2006 |
Randomized, open-label, single-dose, crossover, relative bioavailability study in healthy adults, comparing the pharmacokinetics of rabeprazole granules administered using soft food or infant formula as dosing vehicle versus suspension.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Area Under Curve; Biological Availability; Chromatography, Liquid; Cross-Over Studies; Delayed-Action Preparations; Female; Food; Half-Life; Humans; Infant Formula; Least-Squares Analysis; Male; Proton Pump Inhibitors; Rabeprazole; Sulfides; Suspensions; Tandem Mass Spectrometry; Time Factors | 2012 |
4 other study(ies) available for rabeprazole and rabeprazole-thioether
Article | Year |
---|---|
Stereoselective metabolism of rabeprazole-thioether to rabeprazole by human liver microsomes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Area Under Curve; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Humans; In Vitro Techniques; Microsomes, Liver; Proton Pump Inhibitors; Rabeprazole; Stereoisomerism; Sulfides | 2006 |
In vitro metabolic stability of moisture-sensitive rabeprazole in human liver microsomes and its modulation by pharmaceutical excipients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biotransformation; Buffers; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Compounding; Drug Stability; Excipients; Humans; In Vitro Techniques; Kinetics; Mass Spectrometry; Microsomes, Liver; Models, Biological; Proton Pump Inhibitors; Rabeprazole; Reproducibility of Results; Sulfides; Technology, Pharmaceutical; Water | 2008 |
Simultaneous determination of rabeprazole and its two active metabolites in human urine by liquid chromatography with tandem mass spectrometry and its application in a urinary excretion study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Humans; Rabeprazole; Sulfides; Tandem Mass Spectrometry | 2014 |
Application of a liquid chromatographic/tandem mass spectrometric method to a urinary excretion study of rabeprazole and two of its metabolites in healthy human urine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Chromatography, Liquid; Drug Stability; Female; Humans; Linear Models; Male; Rabeprazole; Reproducibility of Results; Sensitivity and Specificity; Sulfides; Tandem Mass Spectrometry | 2015 |